NCT06604273View on ClinicalTrials.gov

Unravelling Intestinal Fibrosis in Ulcerative Colitis

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

October 3, 2025

Study Completion Date

April 3, 2026

Conditions
Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Fibroblast Activation Protein Inhibitor
Interventions
DIAGNOSTIC_TEST

Fibroblast Activation Protein Inhibitor

PET CT imaging using the fibroblast activation protein inhibitor tracer

Trial Locations (1)

1081BT

RECRUITING

Amsterdam UMC, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER